Axxcess Wealth Management’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$789K Buy
+8,726
New +$731K 0.01% 584
2026
Q1
Sell
-9,133
Closed -$779K 589
2025
Q4
$779K Sell
9,133
-3,812
-29% -$313K 0.01% 563
2025
Q3
$1.01M Sell
12,945
-32
-0.2% -$2.5K 0.02% 443
2025
Q2
$1.01M Buy
12,977
+5,019
+63% +$374K 0.02% 426
2025
Q1
$577K Sell
7,958
-2,687
-25% -$192K 0.02% 516
2024
Q4
$788K Sell
10,645
-1,166
-10% -$81.6K 0.02% 450
2024
Q3
$779K Sell
11,811
-1,948
-14% -$142K 0.02% 450
2024
Q2
$1.27M Sell
13,759
-6,080
-31% -$538K 0.03% 331
2024
Q1
$1.9M Buy
19,839
+1,594
+9% +$134K 0.05% 259
2023
Q4
$1.39M Sell
18,245
-62,401
-77% -$4.34M 0.04% 293
2023
Q3
$5.59M Buy
80,646
+11,353
+16% +$912K 0.19% 101
2023
Q2
$6.54M Buy
69,293
+1,382
+2% +$120K 0.47% 45
2023
Q1
$5.62M Buy
67,911
+2,170
+3% +$171K 0.43% 51
2022
Q4
$4.9M Buy
65,741
+10,064
+18% +$776K 0.4% 53
2022
Q3
$4.6M Buy
55,677
+2,428
+5% +$234K 0.44% 46
2022
Q2
$5.06M Buy
53,249
+1,267
+2% +$131K 0.47% 46
2022
Q1
$6.12M Buy
51,982
+1,815
+4% +$204K 0.48% 44
2021
Q4
$6.5M Buy
+50,167
New +$5.85M 0.47% 46

Other funds holding EW

Axxcess Wealth Management's EW Position: Q2 2026 in Review

Axxcess Wealth Management opened a new position in Edwards Lifesciences (EW) in Q2 2026: 8,726 shares worth $789K. The stake represents 0.01% of the portfolio and ranks #584 among its holdings. This is a return to the name: Axxcess Wealth Management previously reported a position in EW as recently as Q4 2025.

Axxcess Wealth Management first reported a position in EW in Q4 2021 and has held it in 18 quarters since. The position peaked at $6.54M in Q2 2023. 563 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • Axxcess Wealth Management held 8,726 shares of Edwards Lifesciences worth $789K as of Q2 2026.
  • Edwards Lifesciences was a new Axxcess Wealth Management position in Q2 2026.
  • Edwards Lifesciences made up 0.01% of Axxcess Wealth Management's portfolio in Q2 2026, its #584 holding.
  • Axxcess Wealth Management first reported a position in Edwards Lifesciences in Q4 2021 and has held it in 18 quarters since.
  • Axxcess Wealth Management's Edwards Lifesciences position peaked at $6.54M in Q2 2023.
  • 563 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Axxcess Wealth Management's 13F filing for Q2 2026, filed 28 Jul 2026.